Boronic acid derivatives
Frontier Specialty Chemicals 1G 3-FLUORO-5-METHOXYPHENYLBOR
3-Fluoro-5-methoxyphenylboronic acid; CAS No: 609807-25-2
eMolecules 89694-48-4 | (5-Chloro-2-methoxyphenyl)boronic acid | Ambeed | MFCD01318966 | 186.400 | C7H8BClO3 | 98.000 | COc1ccc(Cl)cc1B(O)O | 1g | 552617235
(5-Chloro-2-methoxyphenyl)boronic acid | Ambeed | 89694-48-4 | MFCD01318966 | 186.400 | C7H8BClO3 | 98.000 | COc1ccc(Cl)cc1B(O)O | 1g | 552617235
Aobchem 2-Methoxyphenylboronic acid, AOBCHEM USA 10264-100G. 5720-06-9. MFCD00236047
2-Methoxyphenylboronic acid, AOBCHEM USA 10264-100G. 5720-06-9. MFCD00236047
eMolecules 481725-36-4 | 4-Bromoacetyl-3-fluorophenylboronic acid | Combi-Blocks | MFCD06796423 | 260.850 | C8H7BBrFO3 | 95.000 | OB(O)c1ccc(C(=O)CBr)c(F)c1 | 1g | 117529262
4-Bromoacetyl-3-fluorophenylboronic acid | Combi-Blocks | 481725-36-4 | MFCD06796423 | 260.850 | C8H7BBrFO3 | 95.000 | OB(O)c1ccc(C(=O)CBr)c(F)c1 | 1g | 117529262
eMolecules 137401-45-7 | Boc-DL-2-COOH-Gly-OEt | Ambeed | MFCD09835539 | 247.247 | C10H17NO6 | 95.000 | CCOC(=O)C(NC(=O)OC(C)(C)C)C(O)=O | 25g | 490530529
Boc-DL-2-COOH-Gly-OEt | Ambeed | 137401-45-7 | MFCD09835539 | 247.247 | C10H17NO6 | 95.000 | CCOC(=O)C(NC(=O)OC(C)(C)C)C(O)=O | 25g | 490530529
Medchemexpress LLC 1-Naphthaleneboronic Acid (contains varying amounts of Anhydride) | 13922-41-3 | 100.0% | C10H9BO2 | 25 G
1-Naphthaleneboronic acid is a biochemical reagent useful as a biological material or organic compound for life science research. It is intended for research use only.
- Appears as a white to off-white solid
- Soluble in DMSO at 100 mg/mL (requires sonication)
- Powder can be stored at -20°C for 3 years or 4°C for 2 years
- Solutions can be stored at -80°C for 2 years or -20°C for 1 year
Medchemexpress LLC 3-Tolylboronic acid | 17933-03-8 | 135.96 | 25 G
3-Tolylboronic acid is a biochemical reagent that can be used as a biological material or organic compound for life science related research. This product is intended for research use only.
- Can be used as a biological material
- Can be used as an organic compound for life science research
- Utilized in Suzuki coupling reactions
- Stable as powder for 3 years at -20°C
- Stable as powder for 2 years at 4°C
- Stable in solvent for 6 months at -80°C
- Stable in solvent for 1 month at -20°C
eMolecules 214360-73-3 | 4-Aminophenylboronic acid pinacol ester | AA Blocks LLC | MFCD02093721 | 219.090 | C12H18BNO2 | 0.000 | CC1(C)OB(OC1(C)C)c1ccc(N)cc1 | 10g | 414452002
4-Aminophenylboronic acid pinacol ester | AA Blocks LLC | 214360-73-3 | MFCD02093721 | 219.090 | C12H18BNO2 | 0.000 | CC1(C)OB(OC1(C)C)c1ccc(N)cc1 | 10g | 414452002
Cayman Chemical 17 SHDHA Fatty Acids and Deriv
A hydroxy fatty acid formed from DHA by 15-LO and is a precursor to 17(S)-resolvins; inhibits platelet 12-LO (IC50 = 0.4 μM); inhibits TNF-α-induced expression of IL1B in a human glial cell line (IC50 = ~0.5 nM); inhibits NLRP3 inflammasome formation induced by homocysteine in podocytes at 100 nM
eMolecules 352530-22-4 | Ambeed | 4-Fluoro-3-nitrophenylboronic acid | 1g | 552526430 | A108032 | MFCD08277236 | 184.92 | C6H5BFNO4
Ambeed | (1-Ethyl-1H-pyrazol-4-yl)methanamine | 100mg | 525243407 | A879349 | 856696-09-8 | MFCD02253772 | 125.175 | C6H11N3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC Furan fatty acid F6 (3,4-dimethyl-5-pentyl-2-furanundecanoic acid) | 57818-36-7 | 97.0% | 350.54 | 10 MG
Furan fatty acid F6 (3,4-dimethyl-5-pentyl-2-furanundecanoic acid) is an ester product.
- For research use only.
Apexbio Technology LLC Pemetrexed disodium hemipenta hydrate 357166-30-4 200mg
Pemetrexed disodium hemipenta hydrate (CAS 357166-30-4) is a multitargeted antifolate that inhibits key enzymes in folate metabolism including thymidylate synthase (TS) dihydrofolate reductase (DHFR) and glycinamide ribonucleotide formyltransferase (GARFT) with Ki values for its pentaglutamate form of 1 3 nM 7 2 nM and 65 nM respectively Compared to the monoglutamate form the pentaglutamate exhibits enhanced inhibitory potency particularly against TS and GARFT Pemetrexed is approved for the treatment of advanced non-squamous non-small cell lung cancer In preclinical models it additionally modulates renal uptake of radiolabeled folates These features support its utilization in studies of folate pathway inhibition and cancer therapy